Literature DB >> 12521983

Vaccine induced protection against hepatitis B.

Pierre Van Damme, Jangu E Banatvala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12521983      PMCID： PMC1124991          DOI： 10.1136/bmj.326.7380.105

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.

Authors:  R B Wainwright; L R Bulkow; A J Parkinson; C Zanis; B J McMahon
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

Review 2.  Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.

Authors: 
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

3.  Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy.

Authors:  D J West; B Watson; J Lichtman; T M Hesley; K Hedberg
Journal:  Pediatr Infect Dis J       Date:  1994-08       Impact factor: 2.129

4.  Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children.

Authors:  S S Liao; R C Li; H Li; J Y Yang; X J Zeng; J Gong; S S Wang; Y P Li; K L Zhang
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

5.  Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.

Authors:  Hilton Whittle; Shabbar Jaffar; Michael Wansbrough; Maimuna Mendy; Uga Dumpis; Andrew Collinson; Andrew Hall
Journal:  BMJ       Date:  2002-09-14
  5 in total
  3 in total

1.  Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

Authors:  I Desombere; T Cao; Y Gijbels; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.

Authors:  Brenna C Simons; Philip R Spradling; Dana J T Bruden; Carolyn Zanis; Samantha Case; Tammy L Choromanski; Minjun Apodaca; Hazel D Brogdon; Gaelen Dwyer; Mary Snowball; Susan Negus; Michael G Bruce; Chihiro Morishima; Cindy Knall; Brian J McMahon
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

3.  Effectiveness of the targeted hepatitis B vaccination program in Greenland.

Authors:  Malene L Børresen; Anders Koch; Robert J Biggar; Karin Ladefoged; Mads Melbye; Jan Wohlfahrt; Tyra Grove Krause
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.